Tackling Side Effects and Contraindications All medications have a range of possible adverse effects, and GLP-1 receptor agonists are no exception
However, the pediatric acute liver failure study group has found that in chronic exposure to APAP (in contrast to a single toxic dose), younger patients (median age, 3.5 years) experienced a greater level of hepatotoxicity comparative to older adolescent patients (median age 15.2 years) who were more likely to experience hepatotoxicity from a single toxic dose (Rumack et al., 1981)
Effects depend on peptide type, dose, and individual health
Keep it in the original carton to protect it from light
The answers to these questions, and many more, are yet to be determined but will be crucial to the future of what patient access will look like for these products
Metabolomics studies in the ME/CFS field have investigated metabolite levels using mass spectrometry (MS) or nuclear magnetic resonance (NMR) spectroscopy